Lasa Supergenerics Ltd - Stock Valuation and Financial Performance

BSE: 540702 | NSE: LASA | Pharmaceuticals & Drugs | Small Cap

Lasa Supergenerics Share Price

22.80 0.45 2.01%
as on 21-Feb'25 16:59

DeciZen - make an informed investing decision on Lasa Supergenerics

Overall Rating
M-Cap below 500cr. High Risk from low Liquidity Bole Toh

1. Quality

2. Valuation

Fair

3. Price Trend

asa Supergenerics stock performance -

P/E Ratio (SA):
0.00
Market Cap:
114.2 Cr.
52-wk low:
19
52-wk high:
33.9

Is Lasa Supergenerics Ltd an attractive stock to invest in?

1. Is Lasa Supergenerics Ltd a good quality company?

Past 10 year’s financial track record analysis by Moneyworks4me indicates that Lasa Supergenerics Ltd is a below average quality company.

2. Is Lasa Supergenerics Ltd undervalued or overvalued?

The key valuation ratios of Lasa Supergenerics Ltd's currently when compared to its past seem to suggest it is in the Fair zone.

3. Is Lasa Supergenerics Ltd a good buy now?

The Price Trend analysis by MoneyWorks4Me indicates it is Weak which suggest that the price of Lasa Supergenerics Ltd is likely to Fall in the short term. However, please check the rating on Quality and Valuation before investing.

10 Year X-Ray of Lasa Supergenerics:

Analysis of Financial Track Record

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end
Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end.

Financial track record gives insight into the company's performance on key parameters over the past ten years. MoneyWorks4me’s proprietary colour codes make it easy for retail investors to gauge the company’s past performance.
Lasa Supergenerics Ltd has not performed well majority of the past ten years indicating its past ten year financial track record is not good

Value Creation

Value Creation Index Colour Code Guide

Mar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24TTM
ROCE % 0%0%14.5%12.8%-3.7%6.8%17.1%-3.4%-23.9%-13.2%-
Value Creation
Index
NANA0.0-0.1-1.3-0.50.2-1.2-2.7-2.0-

Growth Parameters

Growth Parameters Colour Code Guide

Sales 00199244170167202137130104126
Sales YoY Gr.-NANA22.5%-30.4%-1.4%21%-32.2%-5.5%-19.5%-
Adj EPS 00501.55.4-5.215.60.1-4.8-3.1-3.2
YoY Gr.-NANA-98.9%-196.7%NA475.3%-97.9%-4091.7%NA-
BVPS (₹) 0-60.210,983.351.346.134.839.131.523.619.319.2
Adj Net
Profit
002.512.3-11.9422.70.6-24-15.6-16
Cash Flow from Ops. 0-0.4-340.440.713.641.39.2-17.32.1-
Debt/CF from Ops. 0-1-38.62.62.13.60.52.2-1.310.3-

CAGR

CAGR Colour Code Guide

9 Years 5 Years 3 Years 1 Years
Sales NA-9.3%-19.8%-19.5%
Adj EPS NANA-182.3%NA
BVPSNA-16%-21%-18.3%
Share Price - -10.2% -21.3% -28.5%

Key Financial Parameters

Performance Ratio Colour Code Guide

Mar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24TTM
Return on
Equity %
006.612.8-10.73.215.10.4-17.4-14.5-16.4
Op. Profit
Mgn %
002316.96.718.223.312.3-3.62.2-0.5
Net Profit
Mgn %
001.35.1-72.411.20.5-18.5-14.9-12.5
Debt to
Equity
0-1.22.10.90.80.30.10.10.20.2-
Working Cap
Days
006613820616911814712313060
Cash Conv.
Cycle
00275339018413329-16

Recent Performance Summary

Sales growth is good in last 4 quarters at 12.94%

Return on Equity is Poor

Sales growth has been subdued in last 3 years -19.81%

Latest Financials - Lasa Supergenerics Ltd.

Standalone Consolidated
TTM EPS (₹) -3.2 -
TTM Sales (₹ Cr.) 126 -
BVPS (₹.) 19.2 -
Reserves (₹ Cr.) 46 -
P/BV 1.19 -
PE 0.00 -
From the Market
52 Week Low / High (₹) 19.00 / 33.94
All Time Low / High (₹) 9.48 / 214.90
Market Cap (₹ Cr.) 114
Equity (₹ Cr.) 50.1
Face Value (₹) 10
Industry PE 37.5

Quarterly Results

 Mar'24 YoY Gr. Rt. %Jun'24 YoY Gr. Rt. %Sep'24 YoY Gr. Rt. %Dec'24 YoY Gr. Rt. %
Sales (₹ Cr.) 3,215 17.32,621 23.93,306 34.33,125 21.1
Adj EPS (₹) 3.5 -19.61.5 4.95.1 3.21.8 58.6
Op. Profit Mgn % 3.53 -131 bps2.80 -38 bps4.50 -104 bps3.06 17 bps
Net Profit Mgn % 1.89 -86 bps1.22 17 bps2.81 -77 bps1.38 39 bps

Management X-Ray of Lasa Supergenerics:

Shareholding Pattern

JavaScript chart by amCharts 3.21.5
JavaScript chart by amCharts 3.21.5Promoters:53.65%Institutions:0%Non-Institutions:46.35%

Promoter's Holding & Share Pledging

JavaScript chart by amCharts 3.21.5Sep22Dec22Mar23Jun23Sep23Dec23Mar24Jun24Sep24Dec2410%20%30%40%50%60%
Pledged *31.1931.1920.6620.7120.6620.6620.6620.6620.6620.66
* Pledged shares as % of Promoter's holding (%)

Valuation of Lasa Supergenerics

MRP
spaceLock icon
MOS
spaceLock icon%
DP
spaceLock icon
Base EPS
spaceLock icon
DPS
spaceLock icon
MRP: ₹ 0
DP: ₹0
Base EPS ₹:
DPS ₹:
MOS (%):
Expected EPS Growth Rate:
0%
Base 0%
50%
Expected Rate of Return:
0%
Base 0%
50%
Future PE:
0
Base 0
200
YTD 1Y 3Y 5Y 10Y Max
YTD 1Y 3Y 5Y 10Y Max
YTD 1Y 3Y 5Y 10Y Max
YTD 1Y 3Y 5Y 10Y Max

Event Update

Login/Register to view analysis.

Analyst's Notes

No data found!

Key Ratios of Lasa Supergenerics

Adj EPS (Rs.)

Sales (Cr.)

ROE (%)

ROCE (%)

Company Name CMP(₹)
Change ₹(%)
Market Cap
Net Sales (₹ Cr.)
Latest EPS (₹)
Net Profit Margin %
Latest P/E
Latest P/BV
Alembic Pharma 802.8 -10.6 (-1.3%) Small Cap 6,229 30.8 9.6 26.4 3.2
Laurus Labs 521.1 -15.4 (-2.9%) Small Cap 5,041 3.7 3.1 144.5 6.9
Piramal Pharma 208.6 -9.5 (-4.3%) Small Cap 4,390 5.2 8.4 42.1 4.1
Ajanta Pharma 2,607.3 -63.1 (-2.4%) Small Cap 4,209 71.9 19 37.2 8.5
Gland Pharma 1,524.3 3.9 (0.3%) Small Cap 4,167 68.1 24.8 22.3 2.7
Natco Pharma 797.8 4.8 (0.6%) Small Cap 3,999 104.1 34.5 7.6 2
Granules India 509 -18.4 (-3.5%) Small Cap 3,755 13.3 11.7 39.7 3.9
Emcure Pharma 996.8 5.2 (0.5%) Small Cap 3,498 8.5 4.4 116.8 6.5
JB Chem & Pharma 1,605.5 -25 (-1.5%) Small Cap 3,299 40.4 16.1 40.4 7.7
Sanofi India 5,076.8 -91.3 (-1.8%) Small Cap 2,851 184.4 20.8 28 15.5
Shows rows:

Profit And Loss

(All Figures are in Crores.)
PARTICULARSMar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24
Sales0199244170167202137130104
Operating Expenses 0153202159137155121136102
Manufacturing Costs01014131618121415
Material Costs0131172128951129110675
Employee Cost 01010121314765
Other Costs 0376131110106
Operating Profit 0464111304716-72
Operating Profit Margin (%) -22.9%16.9%6.5%17.9%23.3%11.7%-5.1%2.1%
Other Income 023100020
Interest 01211882042
Depreciation 0818191716151311
Exceptional Items 0-260000-8-20-9
Profit Before Tax 0215-16529-6-42-19
Tax 003-417-1-43
Profit After Tax 0212-12423-5-39-22
PAT Margin (%) -1.2%5.1%-7.1%2.2%11.3%-3.9%-29.8%-20.8%
Adjusted EPS (₹)0.0472.55.4-5.30.95.6-1.1-7.7-4.3
Dividend Payout Ratio (%)0%0%0%0%0%4%-23%0%0%

Balance Sheet

(All Figures are in Crores.)
PARTICULARSMar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24

Equity and Liabilities

Shareholders Fund 05511710514115915811897
Share Capital 0023234141505050
Reserves 05594821011181086847
Minority Interest000000000
Debt01049069340000
Long Term Debt0816046140000
Short Term Debt0233023200000
Trade Payables0254860341317914
Others Liabilities 04431221936343640
Total Liabilities 0228287255229208209164151

Fixed Assets

Gross Block0132201212220226234229230
Accumulated Depreciation0133150678396110120
Net Fixed Assets0119170162152143137119110
CWIP 0307700553
Investments 000000000
Inventories03342322617111419
Trade Receivables035422921151924
Cash Equivalents 0133641721
Others Assets01023232428202114
Total Assets 0228287255229208209164151

Cash Flow

(All Figures are in Crores.)
PARTICULARSMar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24
Cash Flow From Operating Activity 0-3404114419-172
PBT 0215-165292-22-19
Adjustment 017262725186-48
Changes in Working Capital -0-22133-16-64913
Tax Paid 00-2-400-300
Cash Flow From Investing Activity 00-44-7-2-4-3110
Capex 0-2-47-11-1-7351
Net Investments 00-10-13-651
Others 02340002-2
Cash Flow From Financing Activity 004-33-10-360-4-2
Net Proceeds from Shares 00300330000
Net Proceeds from Borrowing 06-20-15-32-14000
Interest Paid 0-12-11-12-8-20-4-2
Dividend Paid 000000000
Others 067-7-3-20000
Net Cash Flow 0-300216-100
PARTICULARSMar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24
Ratios
ROE (%)N/A8.6514.33-10.812.9415.17-3.37-27.97-20.22
ROCE (%)N/A14.4512.8-3.736.7717.14-3.41-23.94-13.23
Asset Turnover Ratio01.910.950.630.690.930.660.690.66
PAT to CFO Conversion(x)N/A-1.53.33N/A3.51.78N/AN/AN/A
Working Capital Days
Receivable Days05857765432443011
Inventory Days05656796339383658
Payable Days0717815318075594557

Lasa Supergenerics Ltd Stock News

Lasa Supergenerics Ltd FAQs

Company share prices are keep on changing according to the market conditions. The closing price of Lasa Supergenerics on 21-Feb-2025 16:59 is ₹22.80.
Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 21-Feb-2025 16:59 the market cap of Lasa Supergenerics stood at ₹114.2.
The latest P/E ratio of Lasa Supergenerics as of 21-Feb-2025 16:59 is 0.00.
The latest P/B ratio of Lasa Supergenerics as of 21-Feb-2025 16:59 is 1.19.
The 52-week high of Lasa Supergenerics is ₹33.94 and the 52-week low is ₹19.00.
The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Lasa Supergenerics is ₹126.1 ( Cr.) .

About Lasa Supergenerics Ltd

No data to display
You have 2 views remaining as a Guest User. To get DeciZen Rating of 3,500+ Stocks based on their Quality, Valuation and Price Trend Login Now
© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.
Loading...
Hold on